Suraksha Diagnostic Ltd.
SURAKSHA.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.47B
Close$
$69.66
77.4% downside
Current Fair Value
77.4% downsideOvervalued by 77.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.47 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.50 (0.32%) |
| Earnings per Share | $6.18 |
| Beta | 1.57 |
| Outstanding Shares | 52,080,758 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 45.97 |
|---|---|
| PEG | 119.64 |
| Price to Sales | 4.98 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$835.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$896.88 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Suraksha Diagnostic Ltd.
1,600 employees
CEO: Ritu Mittal Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; gen...